Devana Solutions Enhances Advisory Board with Addition of Velocity Clinical Research’s Craig Koch

[Chapel Hill, NC, March 17, 2022] Devana Solutions, the leading cloud SaaS provider to the clinical trials industry to connect centralized research professionals to staff and clinicians at decentralized site locations, announced today that industry veteran Craig Koch has joined Devana’s Advisory Board. Koch is currently Executive Vice President of Velocity Clinical Research, a leading integrated research organization in the U.S. with global expansion now underway. Koch will join current Syneos Health Senior Vice President Tom Wollman and longtime software investor and advisor Reid Conrad currently on Devana’s Advisory Board.

“I am delighted to have Craig join our Advisory Board,” stated Barry Lake, Devana Solutions’ CEO, “Velocity Clinical Research is perhaps the most optimized organization now leveraging our advanced PROPEL enterprise platform, and Craig’s analytical skills and leadership are a big reason why. I look forward to his contributions as an advisor to Devana Solutions, particularly with the transformative development initiatives Devana will be delivering to the industry in 2023.”

“Devana Solutions’ began as a tool for clinical research sites where it will remain the gold standard for research site productivity. The flexibility of the platform and the talent of the team also position Devana to be a Solution poised to unify what is a very disjointed industry.”

Founded in 2017, Velocity has grown dramatically in the last few years and now comprises 30 research sites across the United States with current global expansion underway. The Velocity model represents a new approach to site management. By owning and operating all sites directly, the organization offers a robust infrastructure that completely integrates the sites with singular systems and processes. Their model has proven to provide consistent and predictable patient recruitment and engagement. From a systems perspective, Velocity is an extremely technology-enabled organization, and under Koch’s direction, the Devana Solutions platform lies at the heart of Velocity’s business development, feasibility, and pre-award workflows, and both trial enrollment and overall business performance analytics.

According to Lake, “Craig’s expertise in leveraging our technology and industry insights will be a strong addition to Devana’s Advisory Board and our company. I look forward to his contributions.”

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions’ innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials. https://devanasolutions.com/

About Velocity Clinical Research

Velocity Clinical Research, headquartered in Durham, NC, is the leading integrated site organization for clinical trials, offering dedicated site capabilities to help biopharmaceutical and contract research organization customers find the right patients for their studies. Velocity supports global drug development in primarily conducting phase II and phase III clinical trials. The company has 30 U.S. locations across 14 states. Velocity places the care of the patient at the heart of everything we do. With over 35 years of experience running sites and more than 7,000 studies completed, Velocity has refined its patient recruitment strategies while maintaining a focus on delivering timely and reliable data quality. For more information. visit our website at https://velocityclinical.com.

Devana Solutions Connects Research Operations and Business Intelligence at Scale with Clinical Conductor Integration

A new interface between Devana’s IGNITE and PROPEL products and Advarra’s Cloud-Based Clinical Trial Management System establishes an end-to-end solution for efficient research conduct and world-class business intelligence.

CHAPEL HILL, NC (March 10, 2022)Devana Solutions is pleased to announce a new, at scale CTMS- integration solution for research organizations utilizing Advarra’s Clinical Conductor Clinical Trial Management System (CTMS), improving efficiency, and providing research sites with actionable insights across their entire research portfolio.

The Devana <-> Advarra integration is a dynamic, bi-directional data and process flow between Devana’s IGNITE and PROPEL products, and Advarra’s industry-leading Clinical Conductor CTMS. Following the natural progression of a trial, the trial startup begins in Devana, flows through Clinical Conductor for clinical execution and research operations management, and then back to Devana for end-to-end business intelligence. Enrollment performance metrics are derived automatically and pulled into the Devana system as research teams are interacting with Clinical Conductor, reducing duplicative workflows within the systems.

The robust and sought-after analytics, available within the Devana systems, offer configurable views to analyze performance data, by trial or indication, by site, or organization-wide. Combined with Clinical Conductor’s ability to optimize operational finances, regulatory compliance, and overall operational workflows, these integrated products provide a seamless, comprehensive, clinical research solution. After a very thorough and thoughtful technical approach, the Devana <-> Advarra CTMS integration is now live for all Clinical Conductor customers.

“At Devana Solutions, we have always prided ourselves in listening to our clients and being attentive to their needs,” explained Barry Lake, Devana Solutions’ CEO. “So, when the leadership at highly-valued client-partners, Javara Research and Velocity Clinical Research, encouraged an API-integration with Advarra’s Clinical Conductor CTMS to better support their study teams, we were eager to explore it.”

“We were pleased to work closely with the team at Advarra and the integration of both systems has increased our clients’ operational efficiency. We look forward to deploying the connection for the benefit of additional mutual clients. Working together, as an industry, we can and will move mountains!” added Lake.

“We are thrilled to collaborate with Devana and our customers on this innovative interface,” said James Wurdeman, Chief Product Officer at Advarra. “Devana’s approach to developing this integration aligns with our philosophy of creating site-centric, open, customer-focused technology solutions that can be integrated with enterprise systems across a research site or site network.”

Devana Solutions now boasts integrations with several leading CTMS technologies on the market. These integrations speak to more than just added convenience and increased efficiencies; they’re speeding up the clinical trial process resulting in improved clinical outcomes and therapies to patients.

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials. https://devanasolutions.com/

About Advarra

Advarra makes clinical research safer, smarter, and faster. Our integrated solutions help safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance for over 3,500 sponsors, CROs, institutions, academic medical centers, and research consortia.

With trusted and unequaled independent oversight committee services, innovative software solutions for sites, sponsors, and CROs, and experienced consultants with deep-seated connections across the industry, Advarra has the expertise and technology needed to advance clinical research and help our clients make the world a healthier place.

Headquartered in Columbia, Maryland, Advarra’s extensive geographic reach helps clients navigate the evolving research and regulatory environment. https://www.advarra.com/

Accel Research Sites makes clinical trials more accessible with Devana Solutions’ PROPEL platform

Chapel Hill (February 22, 2022) – Accel Research Sites is bringing clinical trials to even more patients, right where they live and work, thanks to an industry-leading clinical trial platform from Devana Solutions.

Accel is the latest clinical trial network to convert to Devana’s PROPEL Enterprise Platform, which will help the organization connect central teams to site-based staff and clinicians. The company previously used Devana’s IGNITE platform to automate workflow at the start of studies and to gain insight into performance metrics.

“PROPEL literally brings the site to the patient,” according to Barry Lake, Devana Solutions’ CEO and Co-Founder. “Like most leading research site networks, our Accel client-partner has used our IGNITE technology to standardize the trial startup workflows and analytics for their central operations team but, with PROPEL, Accel’s clin-ops professionals collaborate in a common cloud with their site-based colleagues, providing patients with access to trials in the communities where they live and work. We are thrilled that the team at Accel is leading this transformational shift.”

Accel will use PROPEL to connect the centralized management team in Florida with clinicians across 24 sites. With the shift from IGNITE, Accel will see increased efficiencies and precision around site selection, as well as faster site startup and exceptional trial execution.

“When the pandemic hit, we at Accel had to reimagine many of our normal processes so we could both help with the global health crisis and continue to keep our participants healthy and safe,” said Lora Parahovnik, CEO. “Working with Devana has helped us become more efficient. We’re looking forward to continuing to push forward in clinical trial operations by leaning on a cutting-edge platform like PROPEL.”

Devana Solutions is a market leader in clinical trial SaaS for study startup automation, metrics capture and analytics. Accel has been a partner since 2019, recently moving to the PROPEL platform as the company has grown.

For more information about Devana Solutions, visit https://devanasolutions.com/. For more information about Accel Research Sites, visit https://accelresearchsites.com/.

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials.

About Accel Research Sites

Accel Research Sites is a multi-therapeutic network of clinical research sites dedicated to the expert delivery of treatment options to patients and providers. They partner with the most innovative and significant pharmaceutical, biotechnology, and medical device companies worldwide to advance healthcare and wellness in the communities they serve.

SCOPE 2022 Recap: Takeaways from Clinical Ops Executives

The 2022 Summit for Clinical Operations Executives (SCOPE) has come to a close. Clinical operations executives from all parts of North America gathered in Orlando, Florida, to share the latest innovations in clinical trial recruitment, management, and analysis. Devana Solutions CEO and Co-Founder Barry Lake and Vice President of Operations Linda Parks attended the event to keep up with the latest trends and share how Devana Solutions’ cutting-edge platforms help pharmaceutical sponsors and clinical research organizations keep up with the rapid pace of technology adoption.

Our CTMS partners exhibiting were kind enough to refer Devana Solutions as a complementary platform to those stopping by their booths with a need for business development or startup solutions. Special shout-out to Elise Tawfiq of RealTime CTMS, as well as Mia Castagnero and Eric Elander of Clinical Research IO (CRIO) and the entire CRIO team for their hospitality.

We started the week by making history teeing off at SCOPE’s Inaugural Masters of Clinical Research Golf Tournament.

 

 

In between speakers and breakout sessions, the week was filled with talks from industry thought leaders and networking opportunities with colleagues. Since the first day, we were fortunate to spend time discussing the challenges of and solutions to patient recruitment in multisite studies with Trialbee CEO Matt Walz.

We congratulated Rick Riegel, for becoming the most recent member to join the Board of Directors at RealTime CTMS. We know that he will be a great asset to our friends at RealTime CTMS.

Although the clinical research industry is driven by technology, it’s the face-to-face interactions at conferences like these that put our work into perspective: “people caring for people.”

SCOPE 2022 Recap: Takeaways from Clinical Ops Executives with Devana Solutions
From left to right: Centricity CEO and Co-Founder of hyperCORE Jeff Kingsley and Devana Solutions Vice President of Operations Linda Parks at the hyperCORE Kick-Off Luau

 

We met with Jill Johnson, President of WCG’s Clinical Services Organization, to celebrate her study planning and site optimization efforts! Using Devana Solutions PROPEL Enterprise Platform’s ability to provide reliable real-time and historic metrics, WCG can ascertain predictable study performance data by directly connecting their research sites and effortlessly manage study feasibility, track study workflow and milestone completion, and oversee site facilities and equipment.

Lastly, we always enjoy spending time discussing how our companies are innovating and leading the clinical trial space with Florence Healthcare CEO Ryan Jones.

“Year after year, we’re seeing the use of technology in drug development continuing at a breakneck pace. The way we conduct research has changed drastically because of it, and there’s no doubt that this trend will continue,” said Lake.

 

 

Vice President of Operations Linda Parks agrees. Thanks to innovations in data technologies, the world of clinical data management and analytics has seen some impressive advancements in recent years. If you’re looking to stay ahead of the curve with the digitization of healthcare data and its cloud storage, then you need to be able to seamlessly share and analyze performance levels across your entire research network.

“More than sites needing a platform that can keep up with the latest trends, they need a platform that can display actionable data in real-time,” said Parks.

It’s clear that Devana Solutions is the category leader when it comes to innovation in the field of pipeline administration, study startup workflow automation, metric analysis, and data visualization. Thanks to Devana Solutions, clinical trials are becoming more efficient every day.

Devana Brings Cloud-Based Collaboration to Clinical Trial Central Research Teams

Bringing Cloud-Based Collaboration to Clinical Trial Central Research TeamsThe pandemic has had a significant impact on the clinical research industry. In response to the COVID-19 pandemic, regulatory authorities have been calling for an increased adoption of decentralized clinical trials (DCTs). Devana Solutions has been pivotal during this time, helping central research operations teams collaborate safely and remotely on our platform and connect to decentralized site staff serving patients in underserved communities.

As a result, our PROPEL cloud solution has taken off as the superior research site-operations and analytics platform for leading research organizations, conducting decentralized trials, around the globe.

The Benefits of Decentralized Trials

More research organizations are moving to a decentralized trial model because they found success reaching new patients during the pandemic, as patients opted to stay home or avoid massive health care centers as part of their social distancing efforts.

Other advantages of decentralized trials include:

  • Accelerated patient access
  • Improved patient engagement and retention
  • Increased diversity

Challenge: Communication and Exchange of Data

One of the challenges that sites faced as they moved to decentralized trials was the ability to communicate and share data. These teams used to operate alongside the central research operations teams, but now they were operating in alternate locations.

Where central research operations teams had unlimited access to on-premise data and the ease of connecting with someone in-house, they were forced to operate through delayed communication or shared spreadsheets.

The Answer: Devana Solutions

Devana Solutions provided these teams with customized cloud software that brings clinical research sites to patients in these underserved communities so they can benefit from clinical research as a care option.

Devana’s cloud technology also allows highly-skilled research operations professionals to share protocols and other supporting trial documentation with decentralized sites and community-based providers.

More importantly, Devana allows centralized researchers to collaborate with the sites during study start-up and through trial completion, regardless of the trial location.

The future of clinical research is bright. As the industry continues to evolve, Devana Solutions’ capabilities will evolve, as well.

Learn How to Achieve Better Data, Better Decisions, Better Outcomes

Devana Solutions is an innovative cloud software provider that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes.

Book a demo with Devana Solutions today to learn about our cloud-based data analytics software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

Devana Solutions Joins Global Leader in Blood Cancer Fight

Devana Solutions is proud to announce their sponsorship of the Leukemia & Lymphoma Society's Students of the Year program and Grace and Jack Sherner’s Raise Hope Together team.Devana Solutions is proud to announce their sponsorship of Team Raise Hope Together, formed by Grace and Jack Sherner, as part of the Leukemia & Lymphoma Society Students of the Year program. Students of the Year is a philanthropic leadership development program for exemplary high school students that fosters professional skills such as entrepreneurship, marketing, and project management. The students involved in this campaign raise funds for The Leukemia & Lymphoma Society, the world’s largest nonprofit fighting blood cancer.

The Sherners, along with their friend Theo Weiman, formed Team Raise Hope Together in honor of their children’s grandfather, Larry Thayer, who was diagnosed with CLL (Chronic Lymphocytic Leukemia) in 2007.

In April of this past year, their children’s aunt, Betsy, found a tumor on her left breast. Days later, she received a breast cancer diagnosis. In the months since, she has undergone a double mastectomy and a complete hysterectomy.

Devana Solutions is joining to be a part of the generation that puts an end to cancer and provides a monumental impact in the fight.

Devana Solutions’ CEO and Co-founder Barry Lake comments on the effort, “We are proud to support Leukemia & Lymphoma Society and the Students of the Year program. We strive to offer solutions to those committed to the fight against cancer, helping those researchers on the frontline close the gap in eliminating cancer by cutting time and costs in the drug development process. One day, we will defeat cancer!”

The Leukemia & Lymphoma Society is on a mission to cure leukemia, lymphoma, Hodgkin’s disease and myeloma and improve the quality of life for patients and their families. Since 1949, the Leukemia & Lymphoma Society has invested more than $1.5 billion in research to advance therapies and save lives. Today, blood cancer patients live longer because of these advancements made possible by the Leukemia & Lymphoma Society.

The family remains committed to defeating their diagnoses. “I continue to work on my personal recovery, which requires piecing together a new body, mind, and spirit,” their Aunt Betty said.

Join Devana Solutions before March 12 with your donation to Team Raise Hope Together.

Take Clinical Trial Management to the Next Level with LYNK

As a technology provider that connects central trial operations teams with decentralized site staff and clinicians, our goal at Devana Solutions is to help research organizations speed new therapies to patients by automating clinical trial processes and capturing site metrics for analysis and execution.

You may be familiar with PROPEL, our enterprise-level platform for managing an expansive research organization consisting of owned or affiliated investigative sites or study teams. By leveraging the cloud to connect central research operations professionals with site-based clinicians and staff for real-time, clinical trial collaboration, it provides easy access to all of the information on trials, sites, users, and contacts at your organizational level. Organizations such as Velocity Clinical Research use PROPEL to create cohesive operations and improve efficiency within their organization and accelerate study startup.

What you may not be familiar with, however, is LYNK—the site-facing extension of the PROPEL platform that expands the capabilities to key site-level staff. LYNK takes PROPEL one step further, giving sites even more ways to streamline processes and increase efficiency. LYNK is the sites’ personalized interface that allows them to receive and respond to trial opportunities and quickly and easily complete feasibility assessments.

Manage Clinical Trial Opportunities

The LYNK interface will automatically notify the sites when a new clinical trial opportunity is sent by the central team. The site LYNK user can review the specifics of each trial, determine which investigator is best for the project, and instantly provide information that is necessary to complete the feasibility assessment. LYNK’s investigator profiles store all vital documents for the sites’ investigators, such as medical licenses, CVs, and training certificates. With LYNK, sites won’t need to sift through emails, document folders, or physical files, because all of this necessary information is located in one place.

Simplify Feasibility Questionnaires

Thanks to LYNK, the cumbersome feasibility process is simplified. Available in the LYNK dashboard, sites can view any outstanding feasibility questionnaires, which will auto populate with the previously answered, common information that is also found in their site’s profile, including contact information, on-site equipment and staff, and specific areas of therapeutic experience. Because LYNK stores all of the necessary data in site profiles, sites won’t need to search for the information in documents and spreadsheets—it’s available instantly.

These are just a couple of ways LYNK works seamlessly in conjunction with PROPEL, providing benefits not only to the greater research organization but to the sites, as well. Book a demo with Devana Solutions today to discover what LYNK can do to take your sites’ clinical trial management to the next level.

Clinical Trial Tech Stack: Seamless Connectivity For Your Team

Clinical trials have evolved in recent years. There are now more decentralized clinical trials than ever before, thanks to the adoption of cutting-edge technologies. However, in order for these trials to be successful from the beginning, it is essential to select the right tech stack. This can be daunting, but don’t worry; the team at Devana Solutions, a clinical trial software platform, is here to help! Here are the key considerations when selecting your clinical trial technology.

During the pandemic, the industry accelerated its growing adoption of decentralized clinical trials (DCTs). This allowed sites to expand their reach and diversify their patient selection. This approach offers several advantages over traditional clinical trials, including:

  • Improved patient access to cutting-edge therapies;
  • Increased efficiency and cost savings due to the elimination of centralization costs (such as those associated with data management and monitoring); and,
  • Enhanced study feasibility due to the use of innovative technologies.

For thriving enterprises in the clinical trial space, developing the software needed to process their needs could be cumbersome. Considering that there are multiple steps and phases, from the business development through patient trials, it can be a daunting task sorting through the different frameworks, languages, and integrations to deliver an optimal experience for your clinical trial organization.

Fortunately for your organization, Devana Solutions has developed the right solution with its IGNITE and PROPEL systems. Adding in LYNK as a communication and data exchange conduit can also keep your teams synchronized when using PROPEL.

Like any comprehensive tech stack, here are some of the key benefits of Devana Solutions.

  • User interface
  • Data storage and security
  • Application integrations
  • Monitoring and performance tools.

Let’s take a closer look at each of these considerations.

User interface

When selecting clinical trial management software, it is important to ensure that the user interface is easy to use and intuitive. In addition, a good user interface can help improve the exchange of information and data between the central teams and remote sites. It can take time to adapt to new technology.

Data storage and security

As teams exchange and use information, cloud-based applications are the easiest to use and store critical data. Throughout the clinical trials, it is essential to ensure that data is stored and accessed securely. This means using an encrypted database that can be accessed only by authorized users. It is also important to have a backup plan in case of system failure.

Application integrations

The best software allows for integrations to enhance the user experience. Devana Solutions integrates with many platforms, including Real-Time CTMS and Clinical Research IO (CRIO) Devana Solutions client-partners also have the benefit of connectivity with communication and interactive data visualization platforms like Microsoft Outlook, MailChimp, and Tableau. Other client-partners benefit from working with Devana Solutions because of the custom integrations made by our technology team.

Monitoring and performance tools

In order to ensure the success of your clinical trial operations, it is important to have tools in place for monitoring and performance tracking. This includes both real-time and retrospective monitoring of data, as well as dashboards that provide an overview of study progress.

Now that you know what to consider when selecting a tech stack for your clinical trial management software, let’s take a closer look at Devana Solutions.

Devana Solutions

Devana Solutions is an innovative cloud software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

2022 SCOPE Summit: What to Expect

Devana Solutions is attending 2022 SCOPE Summit for Clinical Trial Operations Executives

Leaders in the clinical trial industry are set to meet in Orlando, Florida, at the 2022 SCOPE Summit. The event, which takes place February 7-10 at the Rosen Shingle Creek, brings together clinical operations executives to network and become familiar with the latest developments in the clinical trial management industry. If you are attending, you may already know that this event is the “Who’s Who” of clinical operations executives. If you’re unfamiliar with the annual SCOPE Summit or new to the industry, we’ve put together this look at what to expect.

Variety of Participant Programming

The variety of programs this year is unmatched to meet the growing needs of clinical trial management. We are excited to announce that Devana Solutions CEO Barry Lake and Vice President of Operations Linda Parks are attending to observe and discuss the latest technological and data advancements in the clinical trials industry.

12 Program Tracks

This year, there are 11 programs that cater to pharmaceutical and CRO executives, managers, and scientists.

  • FEASIBILITY & STUDY START-UP PROGRAM

    • Protocol Development, Feasibility, and Global Site Selection
    • Improving Study Start-up and Performance in Multi-Center and Decentralized Trials
  • RECRUITMENT & ENGAGEMENT PROGRAM

    • Enrollment Planning and Patient Recruitment
    • Patient Engagement and Retention through Communities and Technology
  • BUDGETING & RESOURCES PROGRAM

    • Clinical Trial Forecasting, Budgeting and Contracting
    • Resource Management and Capacity Planning for Clinical Trials
  • OUTSOURCING PROGRAM

    • Mastering an Outsourcing Strategy
    • Managing Outsourced Clinical Trials
  • CLINICAL SUPPLY PROGRAM

    • Data Technology for End-to-End Clinical Supply Management
    • Clinical Supply Management to Align Process, Products and Patients
  • DATA PROGRAM

    • Clinical Data Strategy and Analytics
    • Artificial Intelligence in Clinical Research
  • TECHNOLOGY PROGRAM

    • Sensors, Wearables and Digital Biomarkers in Clinical Trials
    • Decentralized Trials and Clinical Innovation
  • REAL-WORLD EVIDENCE PROGRAM

    • Accessing and Generating RWD
    • Leveraging Real-World Data for Clinical and Observational Research
  • BIOMARKERS & BIOSPECIMENS PROGRAM

    • Clinical Biomarkers Operations and Innovation
    • Clinical Biospecimens Technology and Outsourcing
  • QUALITY & MONITORING PROGRAM

    • Risk-Based Quality Management
    • Central and Remote Monitoring
  • MEDICAL DEVICE TRIALS PROGRAM

    • Device Trial Regulations, Quality and Data Management
    • Medical Device Clinical Trial Design, and Operations

As Devana Solutions is a technology partner that research sites, pharmaceutical Sponsors, and CROs rely on to reduce drug development costs and streamline operations, our team is interested in the following events:

  • Feasibility & Study Start-Up Program
    • Protocol Development, Feasibility and Global Site Selection
    • Improving Study Start-up and Performance in Multi-Center and Decentralized Trials
  • Budgeting & Resources Program
    • Clinical Trial Forecasting, Budgeting and Contracting
    • Resource Management and Capacity Planning for Clinical Trials
  • Outsourcing Program
    • Mastering an Outsourcing Strategy
  • Technology Program
    • Decentralized Trials and Clinical Innovation

Breakout Sessions

Bring your pharma, biotech, CRO, site, hospital or patient perspective to each of the discussions of your interest to discuss some of the key issues presented earlier in the day’s sessions.

Lunch and Learn (or Network)

You can enjoy the learning environment as the morning sessions transition into a luncheon presentation. Others would like to take the lunch break as the time to meet with colleagues at one of the 15 restaurants, lounges and various retail shops located right on Rosen Shingle Creek property, including a mini market and ice cream shop.

UPDATE: SCOPE Summit COVID-19 Safety Protocols

SCOPE Summit organizers at the Cambridge Healthtech Institute (CHI) has implemented the following requirements if you are attending the event in person, including:
Provide proof that you have been fully vaccinated against COVID-19
Take a COVID test within 24 hours prior to arriving at the event
Follow all safety protocols set by event staff, including masking

Are you planning on attending the 2022 SCOPE Summit? We’d love to chat. Devana Solutions CEO and Co-founder Barry Lake and Vice President of Operations Linda Parks will be attending the show and are available to discuss how technology can improve your clinical trial management process. Connect with Barry or Linda on LinkedIn or use the contact form at the bottom of the page to set something up before the big event in Orlando!

IMA Clinical Research Adds Devana Solutions’ PROPEL Clinical Trial Data Platform

Bringing the Clinical Trial Site to the Patient: IMA Clinical Research Adds Devana Solutions’ PROPEL Clinical Trial Data Platform

 

While 2021 certainly had its ups and downs, the Devana Solutions team is delighted to say we were able to end the year with a BANG! This past year we focused on accelerating clinical trials through the power of connectivity and data through our new PROPEL Enterprise technology. With the pandemic accelerating the shift to decentralized clinical trials, the PROPEL platform became an invaluable asset to our larger research organization clients. Devana PROPEL is leveraging the cloud to connect central research operations professionals with site-based clinicians and staff for real-time clinical trial collaboration. In short, Devana Solutions is bringing the clinical trial site to the patient. 

Today, Devana Solutions is pleased to announce IMA Clinical Research has made the commitment to adopt the most innovative site operations and analytics platform in the clinical trials industry, Devana PROPEL. “Partnering with Devana Solutions aligns with IMA Clinical Research’s centralization strategy initiated to improve efficiency within our network and accelerate study startup, supporting our mission of advancing the development of novel treatments to patients in need,” said IMA Group CEO & President, Mark Weinberger, Ph.D., MPH. 

With a rapidly growing network of traditional site locations, over 100 satellite sites and a database of over 300,000 patients, IMA Clinical Research represents the ideal client-profile to adopt Devana PROPEL Enterprise. “We are thrilled to welcome IMA Clinical Research onto our PROPEL platform,” commented Barry Lake, Devana Solutions’ CEO and Co-Founder. “They truly are a perfect fit for our technology which uses the power of the cloud to bring the expertise of clinical trials professionals into the diverse community site locations where IMA Clinical Research excels. Their broadly distributed site network allows millions of genetically, socially and racially diverse patient populations in urban centers and underserved locations to access clinical trials as a care option.” 

Patient access to clinical trials and research professionals leveraging advanced technology shouldn’t be limited by geography. They won’t, thanks to cloud-based platforms like Devana Solutions PROPEL and IMA Clinical Research. Stay tuned for a steady stream of new Devana Solutions client-partnership announcements in 2022! 

 

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials. https://devanasolutions.com/ 

About IMA Clinical Research

IMA Clinical Research, a division of The IMA Group, is a physician-founded network of integrated clinical research sites specializing in Phase II-IV clinical trials in multiple therapeutic areas. IMA Clinical Research offers a flexible delivery model for site-based, hybrid and fully decentralized trials through its network of dedicated research clinics, a nationwide array of 100 satellite sites and a rapidly-growing database of over 300,000 patients.  We provide centralized processes for contracting, regulatory, training and patient recruitment ensuring rapid start-up, efficient enrollment and high-quality delivery across our network. For more information visit https://imaresearch.com/ or https://theimagroup.com/

 

1 2 3